Try being less snarky and you'll get better replies.

I steer away from more complicated options strategies that involve buying/selling many different prices and dates of contracts.  In my experience it often leads to an erosion of profits from all of the commission charges required to buy them all.  Also on the inevitable, worthless contracts.  With FDA catalysts the premiums are too high for making near-zero risk set-ups.  I only bet on those which have a promising upside.  The downside is assumed either way, from non-approval or dilution to fund the new drug.  Win-win with few exceptions.

A half covered/ half long strategy with a few OOTM puts works for me 9/10 times.  Assuming that I can get them when my charts say so and the drug candidate has enough buzz behind it.  I don't just play any and all FDA catalysts.  As a scientist I also need to see the data behind the speculation.

Congrats on your profits and good luck to your future trades.

-Shawn (shankapotamus)